Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Vericel Corporation (VCEL)

16.44 0.41 (2.56%)

11-13 16:00

Open:

16.05

Pre. Close:

16.03

High:

16.8

Low:

16.05

Volume:

734,315

Market Cap:

713M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.808 - 16.909

16.909 - 17.007

Low:

15.816 - 15.933

15.933 - 16.044

Close:

16.259 - 16.433

16.433 - 16.599

Technical analysis  (as of: 2018-11-13 4:30:43 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 20.45     One year: 23.89

Support:

Support1: 13.18    Support2: 10.51

Resistance:

Resistance1: 17.51    Resistance2: 20.45

Pivot:

13.38

Moving Averages:

MA(5): 16.45     MA(20): 12.96

MA(100): 12.10     MA(250): 10.41

MACD:

MACD(12,26): 0.97     Signal(12,26,9): 0.40

%K %D:

%K(14,3): 81.19     %D(3): 83.61

RSI:

RSI(14): 67.90

52-Week:

High: 17.51  Low: 3.63  Change(%): 350.4

Average Vol(K):

3-Month: 106357  10-Days 208176

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VCEL has closed below upper band by 20.2%. Bollinger Bands are 216.8% wider than normal. The large width of the bands suggest high volatility as compared to VCEL's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-11-07T13:23:01-05:00
IBI Reports On Vericel: Strong Earnings And Promising Prospects

2018-11-07T03:12:21-05:00
Best Performing Stocks YTD 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

43.35

Shares Float (M)

41.78

% Held by Insiders

3.70

% Held by Institutions

30.80

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-0.260

EPS Est. Current Year

-0.620

EPS Est. Next Year

-0.370

EPS Est. Next Quarter

-0.090

Forward EPS

-0.210

Book Value (p.s.)

7.620

PEG Ratio

Profit Margin

-15.80

Operating Margin

-15.28

Return on Assets (ttm)

-15.9

Return on Equity (ttm)

-23.5

Qtrly Rev. Growth

12.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-9.44

Levered Free Cash Flow (M)

-5.42

Valuation

P/E

-63.23

P/E Growth Ratio

0.03

P/BV

2.16

P/S

337731360.00

P/CF

-75.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-10-16

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.